STOCK TITAN

CareDx (NASDAQ: CDNA) insider Peter Maag plans 27,332-share stock sale after option exercise

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CareDx, Inc. insider Peter Maag filed to sell shares of Common Stock through Morgan Stanley Smith Barney LLC’s Executive Financial Services program. The notice covers 27,332 shares tied to a stock option exercise dated August 7, 2026, with sales on NASDAQ. It also lists prior three‑month sales of 46,963 shares on August 5, 2026 and 75,653 shares on August 4, 2026.

Positive

  • None.

Negative

  • None.
Planned shares to be sold 27,332 shares Common Stock to be sold on NASDAQ related to stock option exercise dated August 7, 2026
Prior sale on August 5, 2026 46,963 shares Common Stock sold during the past three months by Peter Maag
Value of August 5, 2026 sale $2,178,945.34 Dollar amount listed for 46,963 shares of Common Stock sold on August 5, 2026
Prior sale on August 4, 2026 75,653 shares Common Stock sold during the past three months by Peter Maag
Value of August 4, 2026 sale $3,576,851.19 Dollar amount listed for 75,653 shares of Common Stock sold on August 4, 2026
Broker share identifier 27,332 shares Common Stock position listed with Morgan Stanley Smith Barney LLC Executive Financial Services
Stock Option Exercise financial
"Common | 08/07/2026 | Stock Option Exercise | Issuer"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
Executive Financial Services financial
"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"
Common Stock financial
"PETER MAAG ... | Common | 08/05/2026 | 46963 | 2178945.34"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Securities Sold During The Past 3 Months regulatory
"144: Securities Sold During The Past 3 Months"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What share sale is Peter Maag planning according to the CDNA Form 144 filing?

Peter Maag plans to sell 27,332 shares of CareDx Common Stock. The shares relate to a stock option exercise dated August 7, 2026, with sales to be executed on NASDAQ through Morgan Stanley Smith Barney LLC.

Which broker is handling Peter Maag’s planned CDNA stock sale?

The planned sale is handled by Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s office is at 1 New York Plaza, 8th Floor, New York, NY 10004, and the trades are indicated for execution on NASDAQ.

What prior CDNA share sales by Peter Maag are disclosed in this Form 144?

The filing discloses prior three‑month sales of 46,963 shares of Common Stock on August 5, 2026 and 75,653 shares on August 4, 2026. These transactions are listed under securities sold during the past three months.

How much value is associated with Peter Maag’s recent CDNA stock sales?

The August 5, 2026 sale of 46,963 shares is listed at $2,178,945.34, and the August 4, 2026 sale of 75,653 shares is listed at $3,576,851.19. These figures reflect the dollar amounts reported for those transactions.

What transaction type is linked to the upcoming CDNA share sale by Peter Maag?

The upcoming sale of 27,332 shares is linked to a Stock Option Exercise. The issuer is identified as the source of the options, and the transaction is indicated for cash on August 7, 2026.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature